IBEX Limited (NASDAQ:IBEX) CEO Robert Thomas Dechant Sells 3,008 Shares of Stock

IBEX Limited (NASDAQ:IBEXGet Free Report) CEO Robert Thomas Dechant sold 3,008 shares of the stock in a transaction that occurred on Monday, January 27th. The shares were sold at an average price of $22.50, for a total value of $67,680.00. Following the transaction, the chief executive officer now owns 223,633 shares of the company’s stock, valued at $5,031,742.50. This represents a 1.33 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Robert Thomas Dechant also recently made the following trade(s):

  • On Friday, January 24th, Robert Thomas Dechant sold 200 shares of IBEX stock. The shares were sold at an average price of $22.50, for a total transaction of $4,500.00.
  • On Tuesday, January 21st, Robert Thomas Dechant sold 1,792 shares of IBEX stock. The stock was sold at an average price of $22.50, for a total transaction of $40,320.00.

IBEX Stock Performance

Shares of IBEX stock opened at $22.15 on Tuesday. The stock has a 50 day moving average price of $20.91 and a 200 day moving average price of $18.99. IBEX Limited has a 52-week low of $13.00 and a 52-week high of $22.53. The firm has a market capitalization of $371.23 million, a P/E ratio of 11.72 and a beta of 0.78.

IBEX (NASDAQ:IBEXGet Free Report) last released its earnings results on Thursday, November 7th. The company reported $0.48 earnings per share for the quarter. The business had revenue of $129.72 million during the quarter. IBEX had a return on equity of 22.54% and a net margin of 6.57%.

Analyst Upgrades and Downgrades

Separately, Robert W. Baird lifted their target price on IBEX from $23.00 to $26.00 and gave the stock an “outperform” rating in a report on Friday, November 8th. Two equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $21.25.

View Our Latest Report on IBEX

Hedge Funds Weigh In On IBEX

Institutional investors have recently modified their holdings of the stock. FMR LLC grew its stake in IBEX by 314.5% in the third quarter. FMR LLC now owns 2,139 shares of the company’s stock worth $43,000 after purchasing an additional 1,623 shares in the last quarter. R Squared Ltd purchased a new stake in shares of IBEX in the 4th quarter worth $48,000. Public Employees Retirement System of Ohio purchased a new stake in shares of IBEX in the 3rd quarter worth $68,000. SG Americas Securities LLC bought a new position in shares of IBEX during the 4th quarter worth $116,000. Finally, Meeder Asset Management Inc. increased its stake in shares of IBEX by 359.2% during the third quarter. Meeder Asset Management Inc. now owns 10,781 shares of the company’s stock valued at $215,000 after buying an additional 8,433 shares during the period. 81.24% of the stock is owned by hedge funds and other institutional investors.

IBEX Company Profile

(Get Free Report)

IBEX Limited provides end-to-end technology-enabled customer lifecycle experience solutions in the United States and internationally. The company products and services portfolio includes ibex Connect, that offers customer service, technical support, revenue generation, and other revenue generation outsourced back-office services through the CX model, which integrates voice, email, chat, SMS, social media, and other communication applications; ibex Digital, a customer acquisition solution that comprises digital marketing, e-commerce technology, and platform solutions; and ibex CX, a customer experience solution, which provides a suite of proprietary software tools to measure, monitor, and manage its clients' customer experience.

Featured Articles

Insider Buying and Selling by Quarter for IBEX (NASDAQ:IBEX)

Receive News & Ratings for IBEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IBEX and related companies with MarketBeat.com's FREE daily email newsletter.